Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome
Kazumoto Iijima(Kobe Children's Hospital), Kandai Nozu(Kobe Children's Hospital), Riku Hamada, Hidefumi Nakamura(National Center For Child Health and Development), Takeshi Ninchoji(Yokohama City University), Tamaki Morohashi(Hokkaido University Hospital), Masaki Shimizu(Tokyo Medical and Dental University), Takayuki Okamoto(Hokkaido University Hospital), Yoko Ohwada(Dokkyo Medical University), Ryojiro Tanaka(Kobe Children's Hospital), Koichi Nakanishi(University of the Ryukyus), Tomohiko Yamamura(Kobe University), Eriko Tanaka(Kobe University), Tomoyuki Sakai(Tokyo Metropolitan Children's Medical Center), Hiroshi Kaito(Kobe University), Takuo Kubota(Osaka University Hospital), Yoshimitsu Gotoh(Japanese Red Cross Nagoya Daini Hospital), Akihide Konishi, Yuko Shima(Wakayama Medical University), Yasufumi Ohtsuka(Saga University), Shuichi Ito(Yokohama City University), Seiji Tanaka(Kurume University Medical Center), Takeshi Yamada(Nippon Medical School), Kenji Ishikura(Kitasato University), Yohei Ikezumi, Mari S. Oba(Yokohama City University), Koichi Kamei(National Center For Child Health and Development), Naonori Kumagai(Tohoku University), Naoya Fujita(Seirei Hamamatsu General Hospital), Takashi Omori(Kyoto University), Hiroyuki Machida(Tohoku University), Yoshinori Araki(Ulsan College), Mayumi Sako(National Center For Child Health and Development)
Institutional Repositories DataBase (IRDB)
January 31, 2022
Cited by 57
Related Papers
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149